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Outcomes of Shoulder Arthroplasty Performed for
Postinfectious Arthritis
Eric Michael Padegimas, MD, Thema A Nicholson, MS, Stephen Silva, BA, Matthew L Ramsey, MD,
Gerald R Williams, MD, Mark D Lazarus, MD, Surena Namdari, MD
The Rothman Institute of Orthopaedics, Thomas Jefferson University Hospitals, Philadelphia, PA, USA

Background: The purpose of this study was to evaluate the functional outcomes, infection rate, and complications associated
with shoulder arthroplasty for sequelae of prior septic arthritis.
Methods: This is a retrospective cohort study of 17 patients who underwent shoulder arthroplasty for sequelae of septic arthritis.
Patients were analyzed for patient-reported outcomes, complications, and reoperations.
Results: The 17 patients in this cohort were an average age of 65.4 ± 12.2 years old, were 58.8% male, and had an average body
mass index of 27.9 ± 4.1 kg/m2. These patients underwent 14 reverse shoulder arthroplasties (RSAs; 11 after antibiotic spacer
placement), one anatomic total shoulder arthroplasty after antibiotic spacer placement, and two hemiarthroplasties (both after
antibiotic spacer placement). Two patients underwent reoperation (dislocated RSAs). There were four complications (23.5%): two
RSA dislocations, one acromial stress fracture, and one atraumatic rotator cuff tear after hemiarthroplasty. There were no cases
of postoperative wound complications or infection. At an average of 4.1 ± 1.8 years of follow-up for all 17 of 17 cases, the average
visual analogue scale pain score was 4.6 ± 2.3, average Single Assessment Numeric Evaluation Score was 59.3 ± 23.7, average
American Shoulder and Elbow Surgeons Score was 57.6 ± 15.5, and average Simple Shoulder Test was 6.9 ± 2.6 based on “yes”
responses.
Conclusions: Shoulder arthroplasty after septic arthritis had inconsistent functional outcomes and high complication rates but no
reinfection.
Keywords: Shoulder replacement arthroplasty, Infectious arthritis, Complications

Native septic arthritis of the glenohumeral joint is an uncommon but potentially devastating condition.1-3) Particularly, end-stage postinfectious glenohumeral arthritis can
lead to significant pain and disability.4) While there are a
number of studies focusing on arthroplasty options for the
sequelae of septic arthritis in the lower extremity5-11) and
glenohumeral periprosthetic joint infection,12-18) results of
shoulder arthroplasty for postinfectious glenohumeral arthrosis have been less commonly reported.
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There have been a small number of case series on
the results of shoulder arthroplasty for the sequelae of
prior septic arthritis.4,19,20) While these studies found low
reinfection rates, patients sustained high complication and
reoperation rates with marginally improved functional
scores. Patients in these studies were mostly treated prior
to the increased utilization of reverse shoulder arthroplasty (RSA),21-23) with only one study of eight patients utilizing an RSA implant for native, end-stage postinfectious
glenohumeral arthritis.19) Given the clinical difficulty of
treating this population and the limited treatment options
available, we aimed to describe our institutional experience with shoulder arthroplasty in this population. We
hypothesized that these patients uncommonly experience
recurrence of infection and will still have mediocre clinical
outcomes despite utilization of RSA.
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METHODS
Following approval by the Institutional Review Board of
Thomas Jefferson University Hospital, all shoulder arthroplasties were identified by querying of an institutional
shoulder arthroplasty database by International Classification of Diseases, ninth revision, Clinical Modification
(ICD-9-CM). The time period over which this data was
collected was January 2010 through September 2015.
The ICD-9-CM codes utilized were 81.80 (anatomic total
shoulder arthroplasty [aTSA]), 81.81 (partial shoulder
arthroplasty [hemiarthroplasty]), and 81.88 (RSA). Direct
chart review was performed on all patients to obtain the
diagnosis at the time of shoulder arthroplasty. All patients
who underwent arthroplasty for the sequelae of septic
arthritis (pain and shoulder dysfunction in the setting of
prior infectious arthritis) were included. Arthroplasty was
performed after eradication of the infection either through
debridement or placement of an antibiotic spacer and a
course of antibiotics. These patients were not undergoing
arthroplasty as a treatment for a current or acute infection, they were undergoing arthroplasty for the sequelae
of septic arthritis in which the infection had already been
eradicated. Search was performed of our institutional
arthroplasty database rather than individuals that were
coded for a diagnosis of primary septic arthritis for two
reasons. Firstly, in our institutional database, procedures
are coded more reliably than diagnoses. Secondly, all arthroplasty cases were directly chart reviewed, so all arthroplasty cases performed after septic arthritis were known to
be captured. Patients that underwent revision arthroplasty
for periprosthetic joint infection were not included. Those
that underwent arthroplasty after an index antibiotic
spacer placement for septic arthritis or osteomyelitis of the
native shoulder were included in this cohort.
Demographic factors such as age, sex, body mass
index (BMI), and age adjusted Charlson Comorbidity Index were recorded.24) Direct chart review was performed
on these patients to identify postoperative complications,
reinfection, reoperation, and range of motion (ROM; at a
minimum of 1 year after surgery). Additionally, patients
were contacted at a minimum of 2 years after surgery for
patient-reported outcomes. The outcomes analyzed were
visual analogue scale (VAS) pain score, Single Assessment
Numeric Evaluation (SANE) score,25) American Shoulder
and Elbow Surgeons (ASES) score,26) and Simple Shoulder
Test (SST) score.27)
Per protocol at our institution, after a standardized
skin preparation and surgical exposure, the glenohumeral
joint was aspirated with a needle prior to arthrotomy. This
synovial fluid was sent for culture. Once the joint was

opened, tissue from the anterior capsule, inferior capsule,
glenoid, and humeral canal, were sent for culture. Each
culture was placed directly into sterile specimen containers with previously unused instruments. Specimens were
held for 2 weeks and sent for both aerobic and anaerobic
cultures. All procedures were performed at one hospital
with one microbiology laboratory. All patients received a
standard regimen of 2 weeks of antibiotics postoperatively
until the cultures were finalized as negative. The specific
antibiotic utilized was based on the susceptibilities of the
organism isolated from previous surgeries. If patients
had positive cultures, they were kept on antibiotics for at
least 6 weeks with routine clinical follow-up for signs and
symptoms of infection by both the surgical team and the
infectious diseases service at our institution. The decision
to undergo arthroplasty after placement of an antibiotic
spacer was based on clinical improvement and normalization of inflammatory laboratory results (erythrocyte
sedimentation rate and C-reactive protein), and culture
status from most recent surgery or aspiration. All cases
were performed by one of five shoulders and elbow fellowship trained surgeons. Fifteen of 17 cases were done by a
surgeon that has been in practice for over 20 years. One
case was done by a surgeon in practice for over 10 years
and the final case was done by a surgeon 5 years into practice. The specific implant utilized was selected by surgeon’s
preference. These systems were as follows: Zimmer Biomet
(Warsaw, IN, USA), DePuy Synthes (Warsaw, IN, USA),
DJO Global (Vista, CA, USA), and Wright Medical (Memphis, TN, USA). Clinical follow-up after final arthroplasty
was performed at 2, 6, 12 weeks, 6 months, and 1 year with
the treating surgeon and up to a year of follow-up with the
infectious disease team (depending on the treatment protocol) for monitoring of recurrent infection.
Descriptive statistics (mean, standard deviation,
minimum, and maximum) were calculated for demographic factors, postoperative complications, and patientreported outcomes. Comparison of proportions by z
scores was conducted for categorical variables while two
sample t -test assuming unequal variance was conducted
for continuous variables. All statistics were calculated with
Microsoft Excel 2013 (Microsoft, Redmond, WA, USA).

RESULTS
There were 17 patients identified over the 5-year study period that underwent shoulder arthroplasty for the sequelae
of septic arthritis. The average age was 65.4 ± 12.2 years
(range, 46.2 to 81.3 years). This population was 58.8%
male. The average BMI was 27.9 ± 4.1 kg/m2 (21.1 to 36.9
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kg/m2). The average age adjusted Charlson Comorbidity
Index was 3.5 ± 1.5 (range, 1 to 6). Comparatively, over
this same time period, there were 2,463 primary shoulder
arthroplasties and 360 revision shoulder arthroplasties
performed at the same institution. The 2,463 primary
patients had a similar preoperative demographic composition to the study population. They had an average age of
67.4 ± 11.1 years (p = 0.99), BMI of 30.3 ± 6.7 kg/m2 (p =
0.97), age-adjusted Charlson Comorbidity Index of 3.7 ±
1.5 (p = 0.99) and were 47.2% male (p = 0.34). The most

frequent medical comorbidities in the study population
were chronic pulmonary disease (4/17, 23.5%), rheumatic disease (2/17, 11.8%), cardiovascular disease (1/17,
5.9%), chronic kidney disease (1/17, 5.9%), and diabetes
with complications (1/17, 5.9%). Twelve of the 17 patients
(70.6%) had previous surgery before their infection (Table
1). Overall, 16 patients had rotator cuff dysfunction at the
time of arthroplasty (14 irreparable tears, one repairable
tear, and one greater tuberosity malunion).
These 17 patients were treated definitively with 14

Table 1. Previous Surgical History for the Population That Underwent Shoulder Arthroplasty for Infection
Sex

Age
(yr)

Surgery
before
infection

Surgery
for
infection

Culture

Clinical detail

1

Male

61.93

2

4

Staphylococcus epidermidis

Two failed open cuff repairs with infection treated with Keflex before
presentation; four I&Ds

2

Female

74.91

0

2

MSSA

Multifocal septic native arthritis, one shoulder I&D

3

Male

52.68

1

3

Staphylococcus epidermidis

One open rotator cuff repair, developed sinus tract 5
years later, two I&Ds before presentation

4

Female

64.78

5

1

CNS, Propionibacterium acnes Five attempted cuff repairs with symptom recurrence before
presentation (three scope, two open); one I&D

5

Male

76.85

3

1

Unknown (OSH)

6

Male

52.06

1

2

CNS, Propionibacterium acnes Failed open cuff repair before presentation; two I&Ds

7

Female

70.83

5

2

CNS

Distal clavicle excision with frozen shoulder, four MUA and
pain pump placed, infected and washed out before presentation

8

Female

79.88

1

2

Staphylococcus lugdunensis,
Escherichia coli

One scope cuff repair, infected and open I&D before presentation

9

Male

57.78

0

4

MRSA

Two injections, septic arthritis with septic emboli to brain and
endocarditis, three I&Ds before presentation

10

Female

69.25

1

4

CNS, Propionibacterium acnes One cuff repair and capsular release, two I&Ds for infection
before presentation; one antibiotic spacer before 2-stage

11

Male

47.75

2

1

Staphylococcus epidermidis

Two scope labral repairs before presentation; rapidly progressive
glenohumeral arthrosis

12

Male

80.98

0

4

MRSA, Pseudomonas
aeruginosa

Nonoperative proximal humerus malunion, three injections; went for
delayed RSA, but I&D instead

13

Female

77.19

0

2

MSSA

One injection for cuff tear arthropathy and plan for RSA, clinically
infected intraoperatively, spacer placed

14

Female

65.13

2

1

CNS

Failed proximal humerus plate and revised to intramedullary nail,
failed before presentation

15

Male

81.29

0

1

Escherichia coli

One injection, worsened and had scope I&D before presentation

16

Male

52.52

2

2

Unknown (OSH)

Two failed rotator cuff repairs, purulent drainage with
I&D before presentation

17

Male

46.19

1

2

Enterobacter agglomerans

Failed proximal humerus plate with collapse and septic arthritis
before presentation

Patient

Rotator cuff surgery three times before presentation; one I&D

I&D: irrigation and debridement, MSSA: methicillin-sensitive Staphylococcus aureus , CNS: coagulase-negative Staphylococcus aureus , OSH: outside hospital,
MUA: manipulation under anesthesia, MRSA: methicillin-resistant Staphylococcus aureus , RSA: reverse shoulder arthroplasty.
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RSA (82.4%; 11 after an index resection and placement of
an antibiotic spacer, three after a single irrigation and debridement), one aTSA (5.9%; after a resection and placement of an antibiotic spacer), and two hemiarthroplasties
(11.8%; both after a resection and placement of an antibiotic spacer). The 14 patients that underwent RSA were
treated with a reverse implant due to an irreparable and atrophied rotator cuff. The one patient that underwent aTSA
was treated with an anatomic implant in the setting of an
intact rotator cuff. The two patients treated with a hemiarthroplasty had supraspinatus tears that were repaired
intraoperatively. Utilization of an antibiotic spacer was
determined by concern for underlying osteomyelitis or in
the setting of a planned arthroplasty following initial treatment for septic arthritis. The presence of osteomyelitis was

A

identified on preoperative imaging or by clinical concern
intraoperatively. Timing of reimplantation was based on
clinical improvement and normalization of inflammatory
laboratory results (erythrocyte sedimentation rate and C
reactive protein). Thirteen of the 17 patients underwent
arthroplasty through a deltopectoral approach (76.5%)
while four of 17 (33.5%) underwent a superior approach
because of prior surgical incisions. There was substantial
heterogeneity with regards to rotator cuff integrity, stem
length, and utilization of cement (Table 2, Figs. 1 and 2).
Regarding outcomes, two of 17 patients (11.7%)
underwent reoperation at 28 and 64 days postoperatively.
The first patient sustained an atraumatic RSA dislocation and underwent revision of the glenoid and humeral
components that were grossly loose intraoperatively. Intra-

B

C

Fig. 1. Preoperative true anteroposterior (AP) (A), AP (B), and axillary (C) radiographs of an 81-year-old female who had multifocal septic native arthritis
with one previous shoulder irrigation and debridement.

A

B

C

Fig. 2. Three-year postoperative true ante
roposterior (AP) (A), AP (B), and scapular Y
(C) views of an 81-year-old female who had
multifocal septic native arthritis with one
previous shoulder irrigation and debridement
and underwent a two-staged reverse
shoulder arthroplasty.

RSA

Hemiarthroplasty

RSA

RSA

RSA

RSA

RSA

RSA

RSA

aTSA

RSA

RSA

RSA

RSA

Hemiarthroplasty

RSA

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

Irreparable, atrophied cuff

Torn supraspinatus, repaired
(poor quality)

Irreparable, atrophied cuff

Tuberosity malunion

Irreparable, atrophied cuff

Irreparable, atrophied cuff

Intact

Irreparable, atrophied cuff

Irreparable, atrophied cuff

Irreparable, atrophied cuff

Irreparable, atrophied cuff

Irreparable, atrophied cuff

Irreparable, atrophied cuff

Irreparable, atrophied cuff

Torn supraspinatus, repaired

Irreparable, atrophied cuff

Irreparable, atrophied cuff

Rotator cuff status

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

No

No

Yes

Yes

No

Two-stage
procedure

15

52

15

6

18

4

5

36

4

14

3

NA

NA

NA

19

6

NA

Time
between two
stages (wk)

RSA: reverse shoulder arthroplasty, NA: not applicable, aTSA: anatomic total shoulder arthroplasty.

RSA

Procedure
performed

1

Patient

Table 2. Surgical Details for Each Patient

Deltopectoral

Deltopectoral

Deltopectoral

Deltopectoral

Deltopectoral

Deltopectoral

Deltopectoral

Deltopectoral

Deltopectoral

Deltopectoral

Deltopectoral

Superior

Superior

Superior

Deltopectoral

Deltopectoral

Superior

Surgical
approach

Standard

Standard

Standard

Standard

Standard

Standard

Standard

Standard

Standard

Standard

Standard

Standard

Standard

Standard

Standard

Long

Standard

Long versus
standard
length stem

Yes

Uncemented

Yes

Uncemented

Yes

Uncemented

Uncemented

Yes

Uncemented

Uncemented

Yes

Yes

Yes

Yes

Uncemented

Yes

Yes

Antibiotic cement

Negative

Negative

Negative

Negative

Negative

Negative

Staphylococcus epidermidis,
Propionibacterium acnes

Coagulase-negative
Staphylococcus

Negative

Negative

Negative

Micrococcus

Negative

Negative

Staphylococcus epidermidis,
Propionibacterium acnes

Negative

Negative

Culture from arthroplasty
surgery
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operative cultures for this case were negative. The second
patient also sustained an atraumatic RSA dislocation and
underwent revision to a thicker polyethylene component.
There were four complications (23.5%): two aforementioned dislocations, one acromial stress fracture, and one
atraumatic rotator cuff tear after hemiarthroplasty (patient
elected not to undergo conversion to RSA). There were no
cases of postoperative wound complications or reinfection.
Ten of the 14 patients that underwent RSA (71.4%) had
ROM data available at a minimum 1-year follow-up (mean,
2.2 ± 1.7 years). In this cohort, the forward elevation was
110° ± 30.2° (60° to 150°). Regarding patient-reported
outcomes, all 17 patients achieved over a 2-year follow-up.
The average follow-up was 4.1 ± 1.8 years (range, 2 to 8.3
years) for all 17 cases. Average VAS pain score was 4.6 ± 2.3
(range, 0 to 8), average SANE score was 59.3 ± 23.7 (range,
0 to 95), average ASES score was 57.6 ± 15.5 (range, 26.7
to 83.3), and average SST score was 6.9 ± 2.6 (range, 1 to
10) “yes” responses.

DISCUSSION
This analysis reviewed the results of shoulder arthroplasty
in 17 patients with end-stage, postinfectious glenohumeral
arthritis at mid-term follow-up. RSA was the most common treatment choice. There were no recurrent infections
and two patients required further surgery. However, nearly
one quarter of the population sustained a complication
(two RSA dislocations, one acromial stress fracture, and
one rotator cuff tear after hemiarthroplasty) and functional results were mediocre. These complications were
likely a result of the poor quality of the soft tissue envelope
and highlight the difficulty of balancing soft tissue tension
in the setting of multiple previous surgeries as well as the
local destruction of the antecedent infection and initial debridement. The index infection was treated aggressively in
this population. Patients with end-stage post-septic arthritis and concern for underlying osteomyelitis were treated
with multiple debridements and resection arthroplasty
with placement of an antibiotic spacer. All patients were
followed by infectious disease specialists perioperatively
and did not undergo arthroplasty until clinical and serological resolution of concern for infection. This aggressive
approach may have contributed to the reinfection rate of
zero at our institution.
There was only one previous study that included
RSA in treatment of end-stage postinfectious glenohumeral arthritis that was performed by Morris et al.19) and
evaluated results in eight patients. While seven of eight
patients were satisfied with their clinical results and there

were no recurrent infections at an average of 4.4 years of
follow-up, the complication rate was 37.5%. Mean postoperative ASES and SANE scores in the analysis by Morris et al.19) were 78.4 and 59.9, respectively. We reported
a similar SANE score of 59.3 and a complication rate of
23.5% to Morris et al.19) Schoch et al.20) performed the largest case series that analyzed a population of 23 shoulders
treated with either aTSA or hemiarthroplasty for end-stage
postinfectious glenohumeral arthritis. This study reported
a 34.8% complication rate, 21.7% reoperation rate, and a
reinfection rate of 8.7%. Active forward elevation was 112°
in this series of anatomic arthroplasties which is similar to
the 110° that we report with use of RSA. A direct comparison between studies is difficult to interpret because in the
study by Schoch et al.,20) seven of the 23 shoulders (30.4%)
were found to have rotator cuff tears, while the vast majority (94%) of the patients in our study with sequelae of prior
septic arthritis had rotator cuff dysfunction. Our analysis
and these prior studies show consistently limited functional results, but a reasonably low reinfection rate with
only two reinfections across all studies. In knee arthroplasty, similar potential for infection eradication has been
found with two-stage treatment.9) These patients showed
more improved functional outcomes relative to shoulder
infection patients. As antibiotic spacer techniques evolve
further, functional outcomes of second-stage arthroplasty
in the shoulder may also improve.28)
The results of this study must be considered in the
context of its limitations. This is a purely retrospective
study and therefore is subject to all limitations of a retrospective study. The ROM data was particularly limited
as forward elevation was the only consistently measured
data point and this was only available in 10 of 17 of this
population at 1 year. Additionally, patient-reported outcomes were not available preoperatively and so could not
be compared to postoperative outcomes scores. Therefore,
it is difficult to state how much patients improved with
their final functional scores. Finally, the treatment cohort
is admittedly heterogeneous with substantial variability in
terms of prior surgical procedures, rotator cuff integrity,
bone loss, and other factors that could influence outcome.
Finally, these patients only represent a small proportion of
our entire arthroplasty population. Therefore, any meaningful analysis of outcomes between these patients and
other arthroplasty patients would be limited by different
population size and composition. Despite this, we believe
that the heterogeneity apparent in this study reflects the
true clinical experience with this challenging patient population.
Postinfectious arthritis of the shoulder is an uncom-
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mon problem and treatment remains difficult. Shoulder
arthroplasty for this indication does not yield robust
patient-reported outcomes and risks complications. Institutionally, we have found that aggressive treatment of
the antecedent infection has helped optimize results from
a reinfection and complication perspective. Any patient
that initially presented with septic arthritis and a concern
for osteomyelitis or were known to likely need a future
arthroplasty were treated with a resection arthroplasty and

antibiotic spacer early. Importantly, with the presented approach to this problem, there were no recurrent infections
at the mid-term follow-up.

CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was
reported.

REFERENCES
1.

Cleeman E, Auerbach JD, Klingenstein GG, Flatow EL. Septic arthritis of the glenohumeral joint: a review of 23 cases. J
Surg Orthop Adv. 2005;14(2):102-7.

13. Dodson CC, Craig EV, Cordasco FA, et al. Propionibacterium acnes infection after shoulder arthroplasty: a diagnostic
challenge. J Shoulder Elbow Surg. 2010;19(2):303-7.

2.

Jeon IH, Choi CH, Seo JS, Seo KJ, Ko SH, Park JY. Arthroscopic management of septic arthritis of the shoulder
joint. J Bone Joint Surg Am. 2006;88(8):1802-6.

3.

Klinger HM, Baums MH, Freche S, Nusselt T, Spahn
G, Steckel H. Septic arthritis of the shoulder joint: an
analysis of management and outcome. Acta Orthop Belg.
2010;76(5):598-603.

14. Foruria AM, Fox TJ, Sperling JW, Cofield RH. Clinical meaning of unexpected positive cultures (UPC) in
revision shoulder arthroplasty. J Shoulder Elbow Surg.
2013;22(5):620-7.

4.

Mileti J, Sperling JW, Cofield RH. Shoulder arthroplasty for
the treatment of postinfectious glenohumeral arthritis. J
Bone Joint Surg Am. 2003;85(4):609-14.

5.

Dudkiewicz I, Salai M, Chechik A, Ganel A. Total hip arthroplasty after childhood septic hip in patients younger
than 25 years of age. J Pediatr Orthop. 2000;20(5):585-7.

6.

Jerry GJ Jr, Rand JA, Ilstrup D. Old sepsis prior to total knee
arthroplasty. Clin Orthop Relat Res. 1988;(236):135-40.

7.

Jupiter JB, Karchmer AW, Lowell JD, Harris WH. Total hip
arthroplasty in the treatment of adult hips with current or
quiescent sepsis. J Bone Joint Surg Am. 1981;63(2):194-200.

8.

Kim YH. Total arthroplasty of the hip after childhood sepsis. J Bone Joint Surg Br. 1991;73(5):783-6.

9.

Nazarian DG, de Jesus D, McGuigan F, Booth RE Jr. A twostage approach to primary knee arthroplasty in the infected
arthritic knee. J Arthroplasty. 2003;18(7 Suppl 1):16-21.

10. Chen CE, Wang JW, Juhn RJ. Total hip arthroplasty for
primary septic arthritis of the hip in adults. Int Orthop.
2008;32(5):573-80.
11. Lee GC, Pagnano MW, Hanssen AD. Total knee arthroplasty
after prior bone or joint sepsis about the knee. Clin Orthop
Relat Res. 2002;(404):226-31.
12. Brook I, Frazier EH. Infections caused by Propionibacterium species. Rev Infect Dis. 1991;13(5):819-22.

15. Mook WR, Klement MR, Green CL, Hazen KC, Garrigues
GE. The Incidence of propionibacterium acnes in open
shoulder surgery: a controlled diagnostic study. J Bone Joint
Surg Am. 2015;97(12):957-63.
16. Padegimas EM, Lawrence C, Narzikul AC, et al. Future
surgery after revision shoulder arthroplasty: the impact
of unexpected positive cultures. J Shoulder Elbow Surg.
2017;26(6):975-81.
17. Sethi PM, Sabetta JR, Stuek SJ, et al. Presence of Propionibacterium acnes in primary shoulder arthroscopy: results
of aspiration and tissue cultures. J Shoulder Elbow Surg.
2015;24(5):796-803.
18. Updegrove GF, Armstrong AD, Kim HM. Preoperative
and intraoperative infection workup in apparently aseptic revision shoulder arthroplasty. J Shoulder Elbow Surg.
2015;24(3):491-500.
19. Morris BJ, Waggenspack WN Jr, Laughlin MS, Elkousy HA,
Gartsman GM, Edwards TB. Reverse shoulder arthroplasty
for management of postinfectious arthropathy with rotator
cuff deficiency. Orthopedics. 2015;38(8):e701-7.
20. Schoch B, Allen B, Mileti J, Sperling JW, Cofield RH. Shoulder arthroplasty for the treatment of postinfectious glenohumeral arthritis. J Shoulder Elbow Surg. 2014;23(9):132733.
21. Day JS, Lau E, Ong KL, Williams GR, Ramsey ML, Kurtz
SM. Prevalence and projections of total shoulder and elbow
arthroplasty in the United States to 2015. J Shoulder Elbow
Surg. 2010;19(8):1115-20.
22. Kim SH, Wise BL, Zhang Y, Szabo RM. Increasing incidence

351
Padegimas et al. Shoulder Arthroplasty for Postinfectious Arthritis
Clinics in Orthopedic Surgery • Vol. 10, No. 3, 2018 • www.ecios.org

of shoulder arthroplasty in the United States. J Bone Joint
Surg Am. 2011;93(24):2249-54.

comes measures after shoulder surgery. Am J Sports Med.
1999;27(2):214-21.

23. Padegimas EM, Maltenfort M, Lazarus MD, Ramsey ML,
Williams GR, Namdari S. Future patient demand for shoulder arthroplasty by younger patients: national projections.
Clin Orthop Relat Res. 2015;473(6):1860-7.

26. Michener LA, McClure PW, Sennett BJ. American Shoulder
and Elbow Surgeons Standardized Shoulder Assessment
Form, patient self-report section: reliability, validity, and responsiveness. J Shoulder Elbow Surg. 2002;11(6):587-94.

24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new
method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis.
1987;40(5):373-83.

27. Matsen FA 3rd, Ziegler DW, DeBartolo SE. Patient selfassessment of health status and function in glenohumeral degenerative joint disease. J Shoulder Elbow Surg.
1995;4(5):345-51.

25. Williams GN, Gangel TJ, Arciero RA, Uhorchak JM, Taylor DC. Comparison of the Single Assessment Numeric
Evaluation method and two shoulder rating scales: out-

28. Padegimas EM, Narzikul A, Lawrence C, et al. Antibiotic
spacers in shoulder arthroplasty: comparison of stemmed
and stemless implants. Clin Orthop Surg. 2017;9(4):489-96.

